European Journal of Radiology
Volume 62, Issue 2 , Pages 199-204 , May 2007

Evaluation of suspected local recurrence in head and neck cancer: A comparison between PET and PET/CT for biopsy proven lesions

  • Benjamin S. Halpern

      Affiliations

    • Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center/Nuclear Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095-6948, USA
    • Department of Radiology, Division of Musculo-Skeletal and Head and Neck Radiology, Medical University Vienna, Vienna 1090 Währinger Gürtel 18-20, Austria
    • Corresponding Author InformationCorresponding author at: Department of Radiology, Division of Musculo-Skeletal and Head and Neck Radiology, Medical University Vienna, Vienna 1090 Währinger Gürtel 18-20, Austria. Tel.: +43 1 40400 4818; fax: +43 1 40400 4898.
    • ,
  • Kristen Yeom

      Affiliations

    • Department of Radiological Sciences, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095-1721, USA
    • ,
  • Barbara J. Fueger

      Affiliations

    • Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center/Nuclear Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095-6948, USA
    • ,
  • Robert B. Lufkin

      Affiliations

    • Department of Radiological Sciences, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095-1721, USA
    • ,
  • Johannes Czernin

      Affiliations

    • Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center/Nuclear Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095-6948, USA
    • ,
  • Martin Allen-Auerbach

      Affiliations

    • Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center/Nuclear Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095-6948, USA
    • Senior author: UCLA School of Medicine, Nuclear Medicine, 105 CHS, 10833 Le Conte Avenue, Los Angeles, CA 90095-6942, USA. Tel.: +1 310 794 3226; fax: +1 310 206 4899.

Received 2 January 2006 ,Revised 6 June 2006 ,Accepted 24 November 2006.

References 

  1. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42(5 Suppl.):1S–93S
  2. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25(9):1255–1260
  3. Hubner KF, Thie JA, Smith GT, Chan AC, Fernandez PS, McCoy JM. Clinical utility of FDG-PET in detecting head and neck tumors. A comparison of diagnostic methods and modalities. Clin Positron Imaging. 2000;3(1):7–16
  4. Lowe VJ, Kim H, Boyd JH, Eisenbeis JF, Dunphy FR, Fletcher JW. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-d-glucose PET imaging. Radiology. 1999;212(3):799–802
  5. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290(24):3199–3206
  6. Branstetter BFt, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?. Radiology. 2005;235(2):580–586
  7. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med. 2003;44(11):1797–1803
  8. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348(25):2500–2507
  9. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231(1):65–72
  10. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41(8):1369–1379
  11. Goerres GW, Von Schulthess GK, Hany TF. Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR Am J Roentgenol. 2002;179(5):1337–1343
  12. Metz CE. ROC methodology in radiologic imaging. Invest Radiol. 1986;21(9):720–733
  13. Farber LA, Benard F, Machtay M, Smith RJ, Weber RS, Weinstein GS, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography. Laryngoscope. 1999;109(6):970–975
  14. McGuirt WF, Greven K, Williams D, Keyes JW, Watson N, Cappellari JO, et al. PET scanning in head and neck oncology: a review. Head Neck. 1998;20(3):208–215
  15. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med. 1999;26(7):767–773
  16. Laubenbacher C, Saumweber D, Wagner-Manslau C, Kau RJ, Herz M, Avril N, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995;36(10):1747–1757
  17. Kostakoglu L, Wong JC, Barrington SF, Cronin BF, Dynes AM, Maisey MN. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med. 1996;37(11):1771–1773
  18. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19(1):61–77quiz 150–1
  19. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26(4):308–314
  20. Heller MT, Meltzer CC, Fukui MB, Rosen CA, Chander S, Martinelli MA, et al. Superphysiologic FDG uptake in the non-paralyzed vocal cord. Resolution of a false-positive PET result with combined PET-CT imaging. Clin Positron Imaging. 2000;3(5):207–211
  21. Fogarty GB, Peters LJ, Stewart J, Scott C, Rischin D, Hicks RJ. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck. 2003;25(2):138–145
  22. Lapela M, Grenman R, Kurki T, Joensuu H, Leskinen S, Lindholm P, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-d-glucose. Radiology. 1995;197(1):205–211
  23. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope. 2000;110(9):1493–1497
  24. Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope. 2005;115(2):237–243
  25. Slomka PJ. Software approach to merging molecular with anatomic information. J Nucl Med. 2004;45(Suppl. (1)):36S–45S
  26. Yoon DY, Chang KH, Han MH, Kim HD, Kim SH, Kim TK, et al. Re-evaluation of optimal dose of contrast medium for vascular enhancement in CT of the head and neck. Neuroradiology. 1997;39(1):30–34

PII: S0720-048X(06)00525-0

doi: 10.1016/j.ejrad.2006.11.037

European Journal of Radiology
Volume 62, Issue 2 , Pages 199-204 , May 2007

Article Tools

* Image Usage & Resolution